Effects of polyphenols including curcuminoids, resveratrol, quercetin, pterostilbene, and hydroxypterostilbene on lymphocyte pro-inflammatory cytokine production of senior horses in vitro

Veterinary Immunology and Immunopathology

Volumn 173, Issue , 2016, Pages 50-59

  Siard, Melissa H ^a   McMurry, Kellie E ^a   Adams, Amanda A ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Curcumin; Horse; Inflammation; Pterostilbene; Quercetin; Resveratrol

Indexed keywords

ANTIINFLAMMATORY AGENT; CURCUMINOID; CYTOKINE; DIMETHYL SULFOXIDE; FLUNIXIN MEGLUMINE; GAMMA INTERFERON; HYDROXYPTEROSTILBENE; IONOMYCIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYLBUTAZONE; PHORBOL 13 ACETATE 12 MYRISTATE; POLYPHENOL; PTEROSTILBENE; QUERCETIN; RESVERATROL; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; AUTACOID; CURCUMIN; STILBENE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CELL ISOLATION; CELL VIABILITY; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DENSITY GRADIENT; FLOW CYTOMETRY; HEPARINIZATION; HORSE; IN VITRO STUDY; INCUBATION TIME; LYMPHOCYTE; LYMPHOCYTOPOIESIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; VEIN PUNCTURE; AGE; ANALOGS AND DERIVATIVES; ANIMAL; BIOSYNTHESIS; CELL SURVIVAL; DRUG EFFECTS; METABOLISM; VETERINARY;

AGE FACTORS; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELL SURVIVAL; CURCUMIN; CYTOKINES; FLOW CYTOMETRY; HORSES; INFLAMMATION MEDIATORS; LYMPHOCYTES; POLYPHENOLS; QUERCETIN; STILBENES;

EID: 84962704625     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2016.04.001     Document Type: Article

References (62)

1. Adams A.A., Breathnach C.C., Katepalli M.P., Kohler K., Horohov D.W. Advanced age in horses affects divisional history of T cells and inflammatory cytokine production. Mech. Ageing Dev. 2008, 129:656-664.
2. Adams A.A., Katepalli M.P., Kohler K., Reedy S.E., Stilz J.P., Vick M.M., Fitzgerald B.P., Lawrence L.M., Horohov D.W. Effect of body condition, body weight and adiposity on inflammatory cytokine responses in old horses. Vet. Immunol. Immunopathol. 2009, 127:286-294.
3. Ader P., Wessmann A., Wolffram S. Bioavailability and metabolism of the flavonol quercetin in the pig. Free Radic. Biol. Med. 2000, 28:1056-1067.
4. Afman L., Milenkovic D., Roche H.M. Nutritional aspects of metabolic inflammation in relation to health-insights from transcriptomic biomarkers in PBMC of fatty acids and polyphenols. Mol. Nutr. Food Res. 2014, 58:1708-1720.
5. Amarnath Satheesh M., Pari L. The antioxidant role of pterostilbene in streptozotocin-nicotinamide-induced type 2 diabetes mellitus in Wistar rats. J. Pharm. Pharmacol. 2006, 58:1483-1490.
6. Azzolini M., La Spina M., Mattarei A., Paradisi C., Zoratti M., Biasutto L. Pharmacokinetics and tissue distribution of pterostilbene in the rat. Mol. Nutr. Food Res. 2014, 58:2122-2132.
7. Balata G.F., Essa E.A., Shamardl H.A., Zaidan S.H., Abourehab M.A. Self-emulsifying drug delivery systems as a tool to improve solubility and bioavailability of resveratrol. Drug Des. Dev. Ther. 2016, 10:117-128.
8. Belcaro G., Cesarone M.R., Dugall M., Pellegrini L., Ledda A., Grossi M.G., Togni S., Appendino G. Efficacy and safety of Meriva(R), a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern. Med. Rev. 2010, 15:337-344.
9. Beretta C., Garavaglia G., Cavalli M. COX-1 and COX-2 inhibition in horse blood by phenylbutazone, flunixin, carprofen and meloxicam: an in vitro analysis. Pharmacol. Res. 2005, 52:302-306.
10. Bessone F. Non-steroidal anti-inflammatory drugs: what is the actual risk of liver damage?. World J. Gastroenterol. 2010, 16:5651-5661.
11. Birrell M.A., McCluskie K., Wong S., Donnelly L.E., Barnes P.J., Belvisi M.G. Resveratrol, an extract of red wine, inhibits lipopolysaccharide induced airway neutrophilia and inflammatory mediators through an NF-kappaB-independent mechanism. FASEB J. 2005, 19:840-841.
12. Breathnach C.C., Sturgill-Wright T., Stiltner J.L., Adams A.A., Lunn D.P., Horohov D.W. Foals are interferon gamma-deficient at birth. Vet. Immunol. Immunopathol. 2006, 112:199-209.
13. Bryant C.E., Farnfield B.A., Janicke H.J. Evaluation of the ability of carprofen and flunixin meglumine to inhibit activation of nuclear factor kappa B. Am. J. Vet. Res. 2003, 64:211-215.
14. Buhrmann C., Mobasheri A., Busch F., Aldinger C., Stahlmann R., Montaseri A., Shakibaei M. Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. J. Biol. Chem. 2011, 286:28556-28566.
15. Busch F., Mobasheri A., Shayan P., Lueders C., Stahlmann R., Shakibaei M. Resveratrol modulates interleukin-1beta-induced phosphatidylinositol 3-kinase and nuclear factor kappaB signaling pathways in human tenocytes. J. Biol. Chem. 2012, 287:38050-38063.
16. Cheng T.C., Lai C.S., Chung M.C., Kalyanam N., Majeed M., Ho C.T., Ho Y.S., Pan M.H. Potent anti-cancer effect of 3'-hydroxypterostilbene in human colon xenograft tumors. PLoS One 2014, 9:e111814.
17. Chung S., Yao H., Caito S., Hwang J.W., Arunachalam G., Rahman I. Regulation of SIRT1 in cellular functions: role of polyphenols. Arch. Biochem. Biophys. 2010, 501:79-90.
18. Comalada M., Camuesco D., Sierra S., Ballester I., Xaus J., Galvez J., Zarzuelo A. In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-kappaB pathway. Eur. J. Immunol. 2005, 35:584-592.
19. Das N., Sikder K., Bhattacharjee S., Majumdar S.B., Ghosh S., Majumdar S., Dey S. Quercetin alleviates inflammation after short-term treatment in high-fat-fed mice. Food Funct. 2013, 4:889-898.
20. Derochette S., Franck T., Mouithys-Mickalad A., Ceusters J., Deby-Dupont G., Lejeune J.P., Neven P., Serteyn D. Curcumin and resveratrol act by different ways on NADPH oxidase activity and reactive oxygen species produced by equine neutrophils. Chem. Biol. Interact. 2013, 206:186-193.
21. Doucet M.Y., Bertone A.L., Hendrickson D., Hughes F., Macallister C., McClure S., Reinemeyer C., Rossier Y., Sifferman R., Vrins A.A., White G., Kunkle B., Alva R., Romano D., Hanson P.D. Comparison of efficacy and safety of paste formulations of firocoxib and phenylbutazone in horses with naturally occurring osteoarthritis. J. Am. Vet. Med. Assoc. 2008, 232:91-97.
22. Duarte V.M., Han E., Veena M.S., Salvado A., Suh J.D., Liang L.J., Faull K.F., Srivatsan E.S., Wang M.B. Curcumin enhances the effect of cisplatin in suppression of head and neck squamous cell carcinoma via inhibition of IKKbeta protein of the NFkappaB pathway. Mol. Cancer Ther. 2010, 9:2665-2675.
23. Foreman J.H., Ruemmler R. Phenylbutazone and flunixin meglumine used singly or in combination in experimental lameness in horses. Equine Vet. J. Suppl. 2011, 12-17.
24. Franceschi C., Capri M., Monti D., Giunta S., Olivieri F., Sevini F., Panourgia M.P., Invidia L., Celani L., Scurti M., Cevenini E., Castellani G.C., Salvioli S. Inflammaging and anti-inflammaging: a systemic perspective on aging and longevity emerged from studies in humans. Mech. Ageing Dev. 2007, 128:92-105.
25. Franck T., Kohnen S., Grulke S., Neven P., Goutman Y., Peters F., Pirotte B., Deby-Dupont G., Serteyn D. Inhibitory effect of curcuminoids and tetrahydrocurcuminoids on equine activated neutrophils and myeloperoxidase activity. Physiol. Res. 2008, 57:577-587.
26. Freund A., Orjalo A.V., Desprez P.Y., Campisi J. Inflammatory networks during cellular senescence: causes and consequences. Trends Mol. Med. 2010, 16:238-246.
27. Goodrich L.R., Nixon A.J. Medical treatment of osteoarthritis in the horse-a review. Vet. J. 2006, 171:51-69.
28. Gutierres V.O., Campos M.L., Arcaro C.A., Assis R.P., Baldan-Cimatti H.M., Peccinini R.G., Paula-Gomes S., Kettelhut I.C., Baviera A.M., Brunetti I.L. Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s). Evid. Based Comp. Altern. Med. 2015, 2015:678218.
29. Horohov D.W., Sinatra S.T., Chopra R.K., Jankowitz S., Betancourt A., Bloomer R.J. The effect of exercise and nutritional supplementation on proinflammatory cytokine expression in young racehorses during training. JEVS 2012, 32:805-815.
30. Hsu C.L., Lin Y.J., Ho C.T., Yen G.C. The inhibitory effect of pterostilbene on inflammatory responses during the interaction of 3T3-L1 adipocytes and RAW 264.7 macrophages. J. Agric. Food Chem. 2013, 61:602-610.
31. Ingrasciotta Y., Sultana J., Giorgianni F., Fontana A., Santangelo A., Tari D.U., Santoro D., Arcoraci V., Perrotta M., Ibanez L., Trifiro G. Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study. PLoS One 2015, 10:e0122899.
32. Ireland J.L., Clegg P.D., McGowan C.M., McKane S.A., Pinchbeck G.L. A cross-sectional study of geriatric horses in the United Kingdom. part 1: demographics and management practices. Equine Vet. J. 2011, 43:30-36.
33. Jeenger M.K., Shrivastava S., Yerra V.G., Naidu V.G., Ramakrishna S., Kumar A. Curcumin: a pleiotropic phytonutrient in diabetic complications. Nutrition 2015, 31:276-282.
34. Kapetanovic I.M., Muzzio M., Huang Z., Thompson T.N., McCormick D.L. Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats. Cancer Chemother. Pharmacol. 2011, 68:593-601.
35. Katepalli M.P., Adams A.A., Lear T.L., Horohov D.W. The effect of age and telomere length on immune function in the horse. Dev. Comp. Immunol. 2008, 32:1409-1415.
36. Kohnen S., Franck T., Van Antwerpen P., Boudjeltia K.Z., Mouithys-Mickalad A., Deby C., Moguilevsky N., Deby-Dupont G., Lamy M., Serteyn D. Resveratrol inhibits the activity of equine neutrophil myeloperoxidase by a direct interaction with the enzyme. J. Agric. Food Chem. 2007, 55:8080-8087.
37. Kumar A., Sharma S.S. NF-κB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochem. Biophys. Res. Commun. 2010, 394:360-365.
38. Kumar A., Ahuja A., Ali J., Baboota S. Conundrum and therapeutic potential of curcumin in drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 2010, 27:279-312.
39. Literat A., Su F., Norwicki M., Durand M., Ramanathan R., Jones C.A., Minoo P., Kwong K.Y. Regulation of pro-inflammatory cytokine expression by curcumin in hyaline membrane disease (HMD). Life Sci. 2001, 70:253-267.
40. Luna S.P., Basilio A.C., Steagall P.V., Machado L.P., Moutinho F.Q., Takahira R.K., Brandao C.V. Evaluation of adverse effects of long-term oral administration of carprofen, etodolac, flunixin meglumine, ketoprofen, and meloxicam in dogs. Am. J. Vet. Res. 2007, 68:258-264.
41. Lv M., Liu K., Fu S., Li Z., Yu X. Pterostilbene attenuates the inflammatory reaction induced by ischemia/reperfusion in rat heart. Mol. Med. Rep. 2015, 11:724-728.
42. Marcilese N.A., Valsecchi R.M., Figueiras H.D., Camberos H.R., Varela J.E. Normal blood volumes in the horse. Am. J. Physiol. 1964, 207:223-227.
43. Martinez Aranzales J.R., Candido de Andrade B.S., Silveira Alves G.E. Orally administered phenylbutazone causes oxidative stress in the equine gastric mucosa. J. Vet. Pharmacol. Ther. 2015, 38:257-264.
44. McConnico R.S., Morgan T.W., Williams C.C., Hubert J.D., Moore R.M. Pathophysiologic effects of phenylbutazone on the right dorsal colon in horses. Am. J. Vet. Res. 2008, 69:1496-1505.
45. Monreal L., Sabate D., Segura D., Mayos I., Homedes J. Lower gastric ulcerogenic effect of suxibuzone compared to phenylbutazone when administered orally to horses. Res. Vet. Sci. 2004, 76:145-149.
46. Nahar P.P., Slitt A.L., Seeram N.P. Anti-inflammatory effects of novel standardized solid lipid curcumin formulations. J. Med. Food 2015, 18:786-792.
47. Paller C.J., Rudek M.A., Zhou X.C., Wagner W.D., Hudson T.S., Anders N., Hammers H.J., Dowling D., King S., Antonarakis E.S., Drake C.G., Eisenberger M.A., Denmeade S.R., Rosner G.L., Carducci M.A. A phase I study of muscadine grape skin extract in men with biochemically recurrent prostate cancer: safety, tolerability, and dose determination. Prostate 2015, 75:1518-1525.
48. Place N.J., McGowan C.M., Lamb S.V., Schanbacher B.J., McGowan T., Walsh D.M. Seasonal variation in serum concentrations of selected metabolic hormones in horses. J. Vet. Intern. Med. 2010, 24:650-654.
49. Qureshi A.A., Guan X.Q., Reis J.C., Papasian C.J., Jabre S., Morrison D.C., Qureshi N. Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor. Lipids Health Dis. 2012, 11:76.
50. Reed S.K., Messer N.T., Tessman R.K., Keegan K.G. Effects of phenylbutazone alone or in combination with flunixin meglumine on blood protein concentrations in horses. Am. J. Vet. Res. 2006, 67:398-402.
51. Samsami-Kor M., Daryani N.E., Asl P.R., Hekmatdoost A. Anti-inflammatory effects of resveratrol in patients with ulcerative colitis: a randomized, double-blind, placebo-controlled pilot study. Arch. Med. Res. 2015, 46:280-285.
52. Schaaf C., Shan B., Buchfelder M., Losa M., Kreutzer J., Rachinger W., Stalla G.K., Schilling T., Arzt E., Perone M.J., Renner U. Curcumin acts as anti-tumorigenic and hormone-suppressive agent in murine and human pituitary tumour cells in vitro and in vivo. Endocr. Relat. Cancer 2009, 16:1339-1350.
53. Swaminathan S., Cavalli R., Trotta F. Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2016, January 22 [Epub ahead of print]. 10.1002/wnan.1384.
54. Takada Y., Bhardwaj A., Potdar P., Aggarwal B.B. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-κB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene 2004, 23:9247-9258.
55. Tobin T., Chay S., Kamerling S., Woods W.E., Weckman T.J., Blake J.W., Lees P. Phenylbutazone in the horse: a review. J. Vet. Pharmacol. Ther. 1986, 9:1-25.
56. Tome-Carneiro J., Gonzalvez M., Larrosa M., Yanez-Gascon M.J., Garcia-Almagro F.J., Ruiz-Ros J.A., Garcia-Conesa M.T., Tomas-Barberan F.A., Espin J.C. One-year consumption of a grape nutraceutical containing resveratrol improves the inflammatory and fibrinolytic status of patients in primary prevention of cardiovascular disease. Am. J. Cardiol. 2012, 110:356-363.
57. USDA, 2006. Equine 2005, Part I: Baseline Reference of Equine Health and Management, 2005. Fort Collins, CO, pp. #N451-1006.
58. Vazquez Prieto M.A., Bettaieb A., Rodriguez Lanzi C., Soto V.C., Perdicaro D.J., Galmarini C.R., Haj F.G., Miatello R.M., Oteiza P.I. Catechin and quercetin attenuate adipose inflammation in fructose-fed rats and 3T3-L1 adipocytes. Mol. Nutr. Food Res. 2015, 59:622-633.
59. Venkatesan N., Chandrakasan G. Modulation of cyclophosphamide-induced early lung injury by curcumin, an anti-inflammatory antioxidant. Mol. Cell. Biochem. 1995, 142:79-87.
60. Wang C., Sun H., Song Y., Ma Z., Zhang G., Gu X., Zhao L. Pterostilbene attenuates inflammation in rat heart subjected to ischemia-reperfusion: role of TLR4/NF-κB signaling pathway. Int. J. Clin. Exp. Med. 2015, 8:1737-1746.
61. Wei S., Xu H., Xia D., Zhao R. Curcumin attenuates the effects of transport stress on serum cortisol concentration, hippocampal NO production, and BDNF expression in the pig. Domest. Anim. Endocrinol. 2010, 39:231-239.
62. Yoon J.H., Baek S.J. Molecular targets of dietary polyphenols with anti-inflammatory properties. Yonsei Med. J. 2005, 46:585-596.